Barclays Initiates Coverage of Cellectis S.A. - Depositary Receipt (CLLS) with Overweight Recommendation
29/5 02:03
Fintel reports that on May 28, 2026, Barclays initiated coverage of Cellectis S.A. - Depositary Receipt (NasdaqGM:CLLS) with a Overweight recommendation. Analyst Price Forecast Suggests 110.62% Upside...